MHLW 2nd Committee On Drugs Considers New Drug Approvals Including RA Biologic
This article was originally published in PharmAsia News
Executive Summary
The Second Committee on Drugs Five reviewed and accepted for approval five new drugs, including Cimzia, a biological subcutaneous injection for rheumatoid arthritis Nov. 29, the Ministry of Health, Labor, and Welfare announced. The following items were approved: